124 related articles for article (PubMed ID: 28429166)
1. LPS administration increases CD11b
Enomoto T; Takami M; Yamamoto M; Kamijo R
Cytotechnology; 2017 Jun; 69(3):529-537. PubMed ID: 28429166
[TBL] [Abstract][Full Text] [Related]
2. Enhanced dual function of osteoclast precursors following calvarial Porphyromonas gingivalis infection.
Cai X; Li Z; Zhao Y; Katz J; Michalek SM; Feng X; Li Y; Zhang P
J Periodontal Res; 2020 Jun; 55(3):410-425. PubMed ID: 31944305
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression.
Yao Z; Li P; Zhang Q; Schwarz EM; Keng P; Arbini A; Boyce BF; Xing L
J Biol Chem; 2006 Apr; 281(17):11846-55. PubMed ID: 16461346
[TBL] [Abstract][Full Text] [Related]
4. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
[TBL] [Abstract][Full Text] [Related]
5. Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.
Lee K; Kim MY; Ahn H; Kim HS; Shin HI; Jeong D
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946669
[TBL] [Abstract][Full Text] [Related]
6. Synovial macrophage-osteoclast differentiation in inflammatory arthritis.
Danks L; Sabokbar A; Gundle R; Athanasou NA
Ann Rheum Dis; 2002 Oct; 61(10):916-21. PubMed ID: 12228163
[TBL] [Abstract][Full Text] [Related]
7. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone.
Atkins GJ; Kostakis P; Vincent C; Farrugia AN; Houchins JP; Findlay DM; Evdokiou A; Zannettino AC
J Bone Miner Res; 2006 Sep; 21(9):1339-49. PubMed ID: 16939392
[TBL] [Abstract][Full Text] [Related]
8. An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model.
Kimura K; Kitaura H; Fujii T; Ishida M; Hakami ZW; Takano-Yamamoto T
Oral Dis; 2014 Apr; 20(3):319-24. PubMed ID: 23651419
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
Takeshita S; Kaji K; Kudo A
J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
[TBL] [Abstract][Full Text] [Related]
10. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
[TBL] [Abstract][Full Text] [Related]
12. Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis.
De Klerck B; Carpentier I; Lories RJ; Habraken Y; Piette J; Carmeliet G; Beyaert R; Billiau A; Matthys P
Arthritis Res Ther; 2004; 6(3):R220-31. PubMed ID: 15142268
[TBL] [Abstract][Full Text] [Related]
13. Identification of multiple osteoclast precursor populations in murine bone marrow.
Jacquin C; Gran DE; Lee SK; Lorenzo JA; Aguila HL
J Bone Miner Res; 2006 Jan; 21(1):67-77. PubMed ID: 16355275
[TBL] [Abstract][Full Text] [Related]
14. Lineage-committed osteoclast precursors circulate in blood and settle down into bone.
Muto A; Mizoguchi T; Udagawa N; Ito S; Kawahara I; Abiko Y; Arai A; Harada S; Kobayashi Y; Nakamichi Y; Penninger JM; Noguchi T; Takahashi N
J Bone Miner Res; 2011 Dec; 26(12):2978-90. PubMed ID: 21898588
[TBL] [Abstract][Full Text] [Related]
15. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
[TBL] [Abstract][Full Text] [Related]
16. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Looney RJ; Ritchlin CT; Boyce BF; Xing L
Arthritis Rheum; 2004 Jan; 50(1):265-76. PubMed ID: 14730625
[TBL] [Abstract][Full Text] [Related]
17. Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
Kimura K; Kitaura H; Fujii T; Hakami ZW; Takano-Yamamoto T
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):219-27. PubMed ID: 22067001
[TBL] [Abstract][Full Text] [Related]
18. Acute hematopoietic stress in mice is followed by enhanced osteoclast maturation in the bone marrow microenvironment.
Kuzmac S; Grcevic D; Sucur A; Ivcevic S; Katavic V
Exp Hematol; 2014 Nov; 42(11):966-75. PubMed ID: 25051532
[TBL] [Abstract][Full Text] [Related]
19. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
Khapli SM; Mangashetti LS; Yogesha SD; Wani MR
J Immunol; 2003 Jul; 171(1):142-51. PubMed ID: 12816992
[TBL] [Abstract][Full Text] [Related]
20. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]